Danaher
Danaher Launches US, UK Laboratories for Precision Medicine Test Development
The CLIA- and CAP-certified laboratories are intended to accelerate the development of companion diagnostics and complementary diagnostics.
Danaher's Leica Microsystems, Stanford to Develop Spatial Biology Tools for Cancer Drug Screening
The partners will apply microscopy and AI to identify spatial, proteomic, and metabolic changes in tumor microenvironments to predict response to different therapies.
The center, led by Jennifer Doudna and Fyodor Urnov and funded by Danaher, is also developing CRISPR therapies for two rare immune disorders.
Cepheid Nabs CE-IVD Mark for Molecular NPM1 Mutation Test for AML Monitoring
The test quantifies mutant NPM1 mRNA transcripts in peripheral blood specimens from patients with acute myeloid leukemia.
Invitae Sells Archer NGS Research Assays to Integrated DNA Technologies for $48M
IDT has acquired the VariantPlex, FusionPlex, LiquidPlex, and Immunoverse panels, powered by Invitae's anchored multiplex PCR (AMP) technology.